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Abstract
Background: Solitary fibrous tumours (SFTs) in the female genital tract are uncommon. Resection of these tumours
is controversial because it can cause life-threatening haemorrhage. We report a case of vulvar SFT that was excised
in a combined abdominal-sacral approach after preoperative embolisation.
Case presentation: At another hospital, an inoperable intrapelvic tumour was diagnosed in a 34-year-old woman.
Computed tomography and magnetic resonance imaging showed that the uterus, urinary bladder and rectum
were compressed laterally by a pelvic tumour with a maximum diameter of 11 cm. This mass was hypervascular
and had a well-defined border. Transperineal biopsy was performed, and immunostaining revealed that the mass
was an SFT. The tumour was supplied by feeding vessels from the right iliac arteries. First, we embolised the
feeding vessels. Second, we performed surgical resection in a combined abdominal-sacral approach; no blood
transfusion was necessary, and no perioperative complications occurred. The final pathological diagnosis was SFT
that was positive for CD34 and signal transducer and activator of transcription 6 according to
immunohistochemical staining.
Conclusion: During a year of follow-up, the disease did not recur. Treatment of pelvic SFT should aim at complete
resection through various approaches after careful measures are taken to prevent haemorrhage.
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Background
Solitary fibrous tumours (SFTs) were first described by
Klemperer and Rabin in 1931 as mesenchymal tumours of
the pleura [1]. Although SFTs are commonly considered
intrathoracic tumours, approximately 30% of them arise in
various extrapleural sites [2, 3]. Of the extrapleural SFTs,
those in the female genital tract are rare. This tumour is
also characterised by low potential for malignant trans-
formation and by abundant blood vessels. Surgical
excision with curative intent is generally recommended
for the management of this tumour, but controlling bleed-
ing during the operation is often difficult [4, 5]. Surgical
methods are controversial because tumour resection
sometimes causes life-threatening haemorrhage.
We succeeded in complete en bloc resection of vulvar
SFT, without morbidity or the need for blood transfusion,
by a combined abdominal-sacral approach after embolisa-
tion of the vessels supplying blood to the tumour.
Case presentation
A 34-year-old woman was referred to our hospital to
evaluate an asymptomatic pelvic mass detected with
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transvaginal ultrasonography in a private clinic, which
she had visited for treatment of infertility. Computed
tomography (CT) revealed a 112 × 62 × 58 mm hyper-
vascular mass with a well-defined border. This mass
compressed the bladder, uterus and rectum in the peri-
toneum (Fig. 1a). Subsequent contrast medium–en-
hanced and fat-suppressed T1-weighted magnetic
resonance imaging (MRI) then revealed that the tumour
had homogeneously high intensity, and T2-weighted im-
ages showed a mixture of isointensity in the muscles and
high intensity of the tumour, as well as compression of
the bladder, uterus and rectum (Fig. 1b, c). Contrast-
enhanced CT and MRI revealed that the tumour was
supplied with blood from the right pudendal artery. La-
boratory data revealed no abnormalities such as squa-
mous cell carcinoma antigen, carcinoembryonic antigen,
cancer antigen 125, or carbohydrate antigen 19-9. We
performed a transperineal biopsy, and the results of
which established the diagnosis of SFT.
Before surgery, we performed embolisation of the
feeder vessels with an absorbent gelatin sponge to re-
duce intraoperative blood loss because this SFT was
hypervascular, supplied primarily by the right obturator
artery and the internal pudendal artery, according to
angiography (Fig. 1d). The next day, with the patient in
the supine position, we separated the tumour from the
right side of the rectum and uterus through a transab-
dominal approach, which would have been challenging
in a narrow and deep pelvis. Laparotomy was performed
through a midline incision. We approached the paravesi-
cal space and confirmed that the tumour invaded the
retroperitoneal cavity. The tumour was well
Fig. 1 Preoperative imaging findings. a Preoperative contrast medium–enhanced sagittal computed tomography showed a pelvic mass lesion,
measuring 112 × 62 × 58 mm. b T2-weighted sagittal magnetic resonance imaging (MRI) showed a mass with heterogeneous intensity in the
pelvic cavity. c Fat-suppressed contrast medium–enhanced T1-weighted coronal MRI showed a tumour with a relatively homogeneous contrast
effect in the pelvic cavity. d On angiography of the right iliac artery, the solitary fibrous tumour was found to be supplied by the right obturator
artery (black arrow) and the right internal pudendal artery (white arrow)
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encapsulated and had abundant blood vessels around
the tumour. We separated as much of the tumour as
possible from the levator ani. It could be easily separated
from the surrounding muscles. After the wound was
closed, the patient was repositioned into the jackknife
position for resection through the sacral approach. We
made a paramedian skin incision and easily identified
the elastic but hard tumour (Fig. 2). We ensured the ad-
equacy of surgical margins to prevent local recurrence
and minimise bleeding. That is, the adipose tissue is left
to cover the lesion. Finally, the tumour could be re-
moved with en bloc resection. The tumour was com-
pletely excised over a period of 223 min with 250-mL
blood loss, and no blood transfusion was required. We
did not place the drain anywhere. The postoperative
course was uneventful, and she was discharged on post-
operative day 7.
Postoperative pathological study showed that the
tumour was encapsulated and elastic but hard, and the
cut surface was greyish-white (Fig. 3). Microscopic study
confirmed that the tumour capsule was not ruptured
and was covered with adipose tissue. It was then re-
vealed that the tumour consisted of proliferating, rela-
tively small oval and spindle cells with prominent
branching and a hemangiopericytoma-like vascular pat-
tern. Cytological atypia was not significant.
Immunohistochemical staining revealed that the tumour
cells were positive for CD34 and for signal transducer
and activator of transcription 6 (STAT6) (Fig. 4). The
final diagnosis was also SFT. The postoperative course
was uneventful; no adjuvant treatment was given be-
cause complete surgical resection was achieved. In the
year since surgery, the patient has shown no evidence of
tumour recurrence.
Discussion and conclusions
In this case, a solitary fibrous tumour invading the retro-
peritoneum from the vulva was treated successfully by a
combined abdominal-sacral approach after embolisation,
without a need of blood transfusion. To our knowledge,
this is the first case report of the resection of a vulvar
SFT through a combined abdominal-sacral approach.
SFTs are rare soft tissue tumours that commonly arise
in the pleura [1]. Such tumours rarely arise from the fe-
male genital tract, although they have been reported in
various other organs. Nine percent of SFTs occur in the
female genital tract, and only 42 cases, including several
in the retroperitoneum, have been reported so far [5, 6].
Furthermore, only 11 cases of vulvar SFTs have been re-
ported [7]. The management of vulvar SFTs is contro-
versial: The prognosis depends on complete resection of
both extrapleural and pleural SFTs [5], but surgery is
Fig. 2 Intraoperative and postoperative findings of SFT from the sacral view, and postoperative wound. a, b En bloc resection of the tumour
from the pelvic muscle fascia and rectum (white arrow: rectum, block arrow: abdominal cavity) c For tumour resection, the patient was in a
jackknife position, and a lateral paramedian incision was made in the skin
Takahashi et al. World Journal of Surgical Oncology           (2021) 19:92 Page 3 of 7
Fig. 3 Gross of solitary fibrous tumour. Photograph of the tumour. Macroscopically, the tumour was elastic but hard, with an intact capsule and
the cut surface was greyish-white
Fig. 4 Microscopic histological findings. a, b Microscopic findings showed spindle cells with a patternless growth arrangement and enlarged
blood vessels. (a ×40 magnification, b ×100 magnification; haematoxylin and eosin stain). c The tumour cells were strongly positive for CD34
(×100 magnification). d The tumour cells were positive for signal transducer and activator of transcription 6. (×100 magnification)
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difficult because of frequent intraoperative heavy bleed-
ing, which occurs because SFTs in the pelvis are usually
supplied with blood by multiple vessels, such as the
branches of the inferior mesenteric artery or the internal
iliac arteries [8, 9]. Therefore, it is necessary not only to
ensure a sufficient blood supply but also to control
bleeding during surgery.
SFTs are soft tissue tumours with spindle-shaped cells
of mesenchymal origin. From among CD34 immuno-
staining positive soft tissue tumours, we need to differ-
entiate between SFT and dedifferentiated liposarcoma.
Immunohistochemistry for STAT6 protein is useful for
diagnosing SFT [10]. Strong expression of STAT6 in the
nucleus is an ideal diagnostic indicator for SFT with
high sensitivity and specificity [11]. It has been recently
reported that STAT6 stains heterogeneously in the nu-
cleus and cytoplasm in spindle-cell de novo dedifferen-
tiated SFT, and the nerve growth factor-inducible
protein A binding protein 2 (NAB2)-STAT6 gene fusion
was confirmed in this tumour. In our case, the tumour
showed the classical morphology of spindle-shaped cells
with CD34 staining [12]. Moreover, STAT6 was uni-
formly and strongly expressed in the nucleus of these
cells. Therefore, we diagnosed this tumour as a SFT.
Because the tumour extended from the vulva into the
pelvis, we performed the surgery through a combined
abdominal-sacral approach out of concern about the dif-
ficulty in establishing an appropriate surgical field deep
inside the pelvis by laparotomy. For that reason, we first
separated the tumour from the right side of the rectum
and uterus through a transabdominal approach and then
successfully resected the tumour through a transsacral
approach. Most patients with pelvic SFTs have under-
gone laparotomy, but some patients suffer heavy bleed-
ing, which is difficult to control [9, 13]. In one report,
massive bleeding was not avoided even with the
transperineal approach [14]. Katsuno et al. reported that
the transsacral approach was useful for complete resec-
tion of pelvic SFTs [15]; however, this approach carries a
high risk of postoperative complications, such as surgical
site infection and anal dysfunction [16] (Table 1). In an-
other report, surgery with a combined abdominal-sacral
approach was performed for five cases of giant presacral
tumours, and complete resection without massive bleed-
ing was achieved. The advantages of this approach are
that complications are minimised and it allows for
complete resection of a tumour that may be difficult to
remove through other approaches [19]. Thus, a com-
bined abdominal-sacral approach can be an option for
resecting tumours deep in the pelvis.
We embolised feeder vessels to the tumour before sur-
gery to reduce intraoperative bleeding. Preoperative per-
cutaneous arterial embolisation allows for safe and
complete resection in cervical, thoracic and lumbar loca-
tions in the spinal cord [20, 21]. Embolisation for pelvic
SFT has been reported; Soda et al. reported that a
tumour was resected after blood flow block was achieved
by an intraoperatively inserted aortic balloon catheter,
and the resulting blood loss was 13,660 mL [9]. On the
other hand, in other reports, the feeder vessels of SFTs
were selectively embolised before operation, which re-
sulted in less intraoperative blood loss without the need
for blood transfusion [14, 17, 22, 23]. In addition, in two
reports, preoperative embolisation did not have the ef-
fect of shrinking the tumour [17, 22]. In our case, we
used an absorbable gelatin sponge that has been re-
ported to be pregnant after using it for uterine artery
embolisation because she desired for a baby. It is known
to be absorbed within 2–6 weeks [18]; therefore, it is
reasonable to perform surgery within 2 weeks. There-
fore, we performed surgery the day after embolisation. It
was possible to complete surgery without blood
Table 1 Summary of surgical outcomes of solitary fibrous tumours in the female pelvis
Author Age Tumor size
(cm)
Way of operation Estimated blood
loss (g)
Complication Follow-up (months)
Wat, et al. [13] 63 14x11x14 Laparotomy 8,000 Blood transfusion N/A
Soda, et al. [9] 27 16x9x14 Laparotomy 13,660 Blood transfusion, aortic
balloon catheter




56 9x7.5x5 Trans-sacral approach 267 No Free of disease 20 months after
the excision
Kim, et al. [4] 52 12x9x9 Laparotomy Massive
hemorrhage






Less than 200 Permanent colostomy Free of disease 13 months after
the excision
Yuza, et al. [18] 46 17 TAE→Laparotomy 335 Ileostomy Free of disease 2 years after the
excision
Present case 34 11x6x6 TAE→Abdominal-sacral
approach
250 No Free of disease 6 months after
the excision
Abbreviation: TAE trans-arterial embolisation
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transfusion by performing preoperative embolisation.
Therefore, embolisation may control intraoperative
bleeding, but it is not effective in reducing tumour vol-
ume. In addition, selective embolisation of the feeding
vessels is more appropriate than intraoperative aortic
occlusion.
In summary, we completely resected a vulvar SFT
without blood transfusion. This tumour is very rare,
nonmetastatic and characterised by abundant blood ves-
sels. The main treatment for SFTs is surgical resection.
However, pelvic SFTs carries the risk of massive bleed-
ing and organ damage, and inadequate tumour resection
can lead to local recurrence. Preoperative embolisation
of feeder arteries reduced intraoperative bleeding in our
patient. In addition, use of the abdominal-sacral ap-
proach can reduce perioperative complications. This
combination thus has potential in the treatment of pelvic
SFTs.
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